Pharmaceutical firms losing business to darknet drug deals
For the $300 billion pharmaceutical industry, the rapid growth of illegal underground marketplaces is a serious threat to profits and reputations.
Bloomberg News
Articles
Supreme Court could weigh in on student debt battle
The lawsuit asks the court to clarify 1970s-era rules that prevent borrowers from getting rid of education debt in bankruptcy, except in cases in which repaying it would constitute an “undue hardship.”
Lilly competitor fails to win FDA backing for diabetes treatment
AstraZeneca Plc didn’t receive U.S. approval for a new diabetes treatment that combines two of its existing drugs. The combination would have competed with Glyxambi from Lilly.
Southwest fixes computer failure, sees normal flight schedule
Southwest Airlines Co. said it has fixed computer system failures that delayed hundreds of flights around the United States over the weekend.
UPDATE: Lilly halts work on potential blockbuster cholesterol drug
Eli Lilly shares plunged nearly 10 percent Monday morning after it said it would stop development of evacetrapib, an experimental cholesterol drug with blockbuster potential.
Lilly expands China drug partnership in growing cancer market
Suzhou, China-based Innovent could receive payments totaling more than $1 billion if the cancer products it develops with Lilly reach certain milestones.
Obama travels narrow road toward trade-pact approval
President Barack Obama needs to hold together a razor-thin majority of pro-trade lawmakers in the U.S. Congress to win approval of his huge Asia-Pacific trade deal.
Delta sues Republic Airways over flights lost to pilot dispute
Indianapolis-based Republic has been unable to fulfill an unspecified number of flights for Delta’s regional operation, Delta Connection, according to the suit filed Monday.
Butler called lone exception to ‘Field of Dreams’ approach
Building or investing in sports facilities in order to boost finances at a university is nearly always a losing play, according to financial experts.
NCAA athletes face long next yard in bid for free-market pay
College athletes are heading back to court in pursuit of pay for play one day after a major setback in their quest for a larger share of the multibillion-dollar industry.
Mall owner that spurned Simon takeover makes $2.3B deal
Macerich Co. has agreed to sell minority stakes in eight U.S. malls for $2.3 billion to Singapore’s GIC Pte and property investor Heitman LLC.
Puerto Rico plans new corporate tax to replace excise levy
Puerto Rico officials are looking to replace an expiring tax with a new levy to draw much-needed revenue from the world’s best-selling medications while seeking to avoid driving U.S. manufacturers such as Eli Lilly and Co. from the commonwealth.
Republic Airways shares soar after pilot agreement reached
Shares in Republic Airways Holdings Inc. jumped almost 80 percent Monday after the company reached a tentative agreement with its pilots union that eases concerns of a possible bankruptcy filing.
House Speaker Boehner to resign from Congress next month
In a stunning move, House Speaker John Boehner informed fellow Republicans on Friday that he would resign from Congress, giving up his top leadership post and his seat in the House in the face of hardline conservative opposition.
Volkswagen to be subpoenaed in probe by 27 states
A majority of U.S. states, including Indiana, have begun a joint investigation of Volkswagen AG in the widening fallout from the company’s admission that 11 million of its diesel vehicles use software to cheat emissions tests.
VW not first manufacturer to use deceptive emissions tactics
Almost as soon as governments began testing vehicle emissions, automakers and engine manufacturers found ways to cheat. Indiana-based Cummins Inc., for instance, was involved in a high-profile case in the late 1990s.
Clinton promises health insurance merger scrutiny in plan
Hillary Clinton said she would give close scrutiny to health-insurance industry mergers like those proposed this year by Anthem Inc. and Aetna Inc., part of the Democratic presidential candidate’s latest policy plans.
Indiana lawmakers push regulator to help Alcoa
Beer is giving one top U.S. financial regulator a headache. And so is a group of Indiana lawmakers, who want friendlier treatment for one of the state’s big employers.
Purdue’s Chao Center regains drug, slashes $360-per-pill price
An Indiana not-for-profit has dropped the price of a drug for multi-drug resistant tuberculosis roughly 90 percent after re-acquiring rights to the medicine from Rodelis Therapeutics.
Anthem, Aetna defend acquisitions called harmful by hospitals
Anthem Inc. CEO Joseph Swedish and Aetna Inc. CEO Mark Bertolini will tell federal lawmakers Tuesday that the deals are necessary to succeed in a changing health-care landscape.